Creon 12000 [USP'U] / 38000 [USP'U] / 60000 [USP'U] capsule, delayed release pellets

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants AbbVie Inc. names for other drugs.

Recalls

• Mar 15, 2021 · Class II · Cardinal Health Inc.
  CGMP Deviations: Intermittent exposure to temperature excursion during storage.
  Lots: 1139494
• Sep 15, 2014 · Class II · AbbVie Inc
  Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
  Lots: Lot #: 1020156; Expiry: 3/31/2016

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Pancrelipase Amylase and Pancrelipase Lipase and Pancrelipase Protease: every company that makes it

Form

capsule, delayed release pellets, oral

Strength

12000 [USP'U] / 38000 [USP'U] / 60000 [USP'U]

Approval

BLA BLA020725

On the market since

Oct 12, 2023

Package NDCs

0032-0047-30 0032-0047-70

Official label

DailyMed (National Library of Medicine), updated Feb 28, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?